I'm in a new phase of the trial. Not an official "phase". But my last infusion was in January. I had an end-of-April scan and whatever it is they see on the images, is stable-to-slightly-smaller. For the purpose of the trial, they want me to get scans at 3-month intervals for the next year.
Saw this article in the WSJ the other day. One of the two drugs I received, Opdivo, is mentioned in the article. Like the other drug mentioned, Keytruda, Opdivo is an "Anti-PD1" treatment, meaning the two drugs are very similar. One interesting point the article makes is, "Researchers still haven't determined how long patients should take the drugs." My trial was 96 weeks, just shy of two years.
(Click on pic to see whole article.)
Saw this article in the WSJ the other day. One of the two drugs I received, Opdivo, is mentioned in the article. Like the other drug mentioned, Keytruda, Opdivo is an "Anti-PD1" treatment, meaning the two drugs are very similar. One interesting point the article makes is, "Researchers still haven't determined how long patients should take the drugs." My trial was 96 weeks, just shy of two years.
(Click on pic to see whole article.)

Comments
Post a Comment